Back to Search
SANDRA QUEZADA, MD
MD
Gastroenterology Physician
NPI: 1609911387IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
D76345(MD)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Education
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
Class of 2006
Research & Publications (18)
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists.
PMID 19659765·Clin Exp Immunol·2009
6-review
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies.
PMID 19581407·J Exp Med·2009
7-preclinical
Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
PMID 18759925·Immunol Rev·2008
6-review
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma.
PMID 18725522·J Exp Med·2008
7-preclinical
Racial differences in disease extent and severity in patients with ulcerative colitis: a retrospective cohort study.
PMID 18273704·Dig Dis Sci·2008
4-observational
Sex hormone-binding globulin expression in the endometria of women with polycystic ovary syndrome.
PMID 17097651·Fertil Steril·2007
8-other
Virulent Salmonella enterica serovar typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells.
PMID 17057096·Infect Immun·2006
7-preclinical
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.
PMID 16778987·J Clin Invest·2006
7-preclinical
Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome.
PMID 16580389·Fertil Steril·2006
4-observational
Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
PMID 16464564·Curr Opin Immunol·2006
6-review
Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: the interplay of clonal anergy and immune regulation.
PMID 16002673·J Immunol·2005
7-preclinical
Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism.
PMID 15699103·J Immunol·2005
7-preclinical
Potential action of androstenedione on the proliferation and apoptosis of stromal endometrial cells.
PMID 15588330·Reprod Biol Endocrinol·2004
8-other
CD40/CD154 interactions at the interface of tolerance and immunity.
PMID 15032580·Annu Rev Immunol·2004
6-review
Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis.
PMID 13130474·Arthritis Rheum·2003
7-preclinical
Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation.
PMID 12750162·Blood·2003
7-preclinical
The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
PMID 12421935·J Immunol·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 22 S GREENE ST, MEDICINE, N3E09
BALTIMORE, MD 21201 - Phone
- (410) 706-3387
Quick Facts
- NPI
- 1609911387
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 20
- Publications
- 18
Are you this provider?
Claim Your Profile